Delivery Order SPE2DB22D3301-SPE2DB25FY8QE
- Not listed
- The Defense Logistics Agency awarded a $5,458.39 delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials. This delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, operates under a firm fixed-price contract type with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract action under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,458.39, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceuticals. It is a firm fixed-price, non-set-aside contract with a performance period ending on May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceutical products. The award, valued at $15,962.76, has an ultimate completion date of August 12, 2024. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,564,376,730 units of the pharmaceutical product PHESGO (1,200-600MG-30,000 unit, 15ML) at a ceiling value of $8,159.16. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,683.68, is for the delivery of PHESGO, a pharmaceutical product, in the amount of 1,200-600MG-30,000 units of 15ML. The contract is a firm fixed-price delivery order, with a completion date of July 28, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,458.39, is a Firm Fixed Price Delivery Order for PHESGO 600-600 MG-20,000 UNIT 10ML. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award is for the delivery of pharmaceutical product PHESGO 600-600 MG-20,000 UNIT 10ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,916.78, is for the delivery of the product "PHESGO 600-600 MG-20,000 UNIT 10ML." This is a firm fixed-price delivery order contract with an ultimate completion date of March 3, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
- This is a $27,291.95 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of PHESGO 600-600MG 1S medical products. The contract has an ultimate completion date of July 24, 2025 and is not set aside. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a $8,225.29 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide PHESGO 1,200-600MG-30,000 UNIT 15ML medical supplies. There is no set-aside designation for this contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8QEDelivery Order
The Defense Logistics Agency awarded a $5,458.39 delivery order to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products totaling 20,000 units in 10ml formulations. This competitively awarded, firm fixed-price delivery order is expected to be completed by August 21, 2025, with performance based at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this prime contract vehicle, AmerisourceBergen supplies specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/31/25 |